These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 1124148)

  • 21. A pilot study of chronic recombinant interferon-alfa 2a for diabetic proliferative retinopathy: metabolic effects and opthalmologic effects.
    Skowsky WR; Siddiqui T; Hodgetts D; Lambrou FH; Stewart MW; Foster MT
    J Diabetes Complications; 1996; 10(2):94-9. PubMed ID: 8777337
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The regional distribution of diabetic retinopathy lesions may reflect risk factors for progression of the disease.
    Bek T; Helgesen A
    Acta Ophthalmol Scand; 2001 Oct; 79(5):501-5. PubMed ID: 11594988
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quantifying early diabetic retinopathy.
    Howard-Williams JR; Peckar CO; Holman RR; Turner RC; Bron AJ
    Diabetologia; 1986 Nov; 29(11):761-6. PubMed ID: 3817334
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pituitary ablation for diabetic retinopathy.
    Speakman JS; Mortimer CB; Briant TD; Ezrin C; Lougheed WM; Clarke WT
    Can Med Assoc J; 1966 Mar; 94(13):627-35. PubMed ID: 5907943
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diabetic retinopathy.
    Kohner EM; Oakley NW
    Metabolism; 1975 Sep; 24(9):1085-102. PubMed ID: 1097858
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of diabetic retinopathy: pituitary ablation and retinal photocoagulation.
    Balodimos MC
    Med Clin North Am; 1971 Jul; 55(4):989-99. PubMed ID: 4946765
    [No Abstract]   [Full Text] [Related]  

  • 27. Long-term follow-up of patients who underwent yttrium-90 pituitary implantation for treatment of proliferative diabetic retinopathy.
    Sharp PS; Fallon TJ; Brazier OJ; Sandler L; Joplin GF; Kohner EM
    Diabetologia; 1987 Apr; 30(4):199-207. PubMed ID: 2439401
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Naftidrofuryl in the treatment of simple diabetic retinopathy. A double-blind study].
    Klein M; Hirche H
    Klin Monbl Augenheilkd; 1985 Sep; 187(3):195-201. PubMed ID: 3906248
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Caclium dobesilate in diabetic retinopathy.
    Sévin R; Cuendet JF
    Ophthalmologica; 1969; 159(1):126-35. PubMed ID: 5369367
    [No Abstract]   [Full Text] [Related]  

  • 30. Fundus photographic risk factors for progression of diabetic retinopathy. ETDRS report number 12. Early Treatment Diabetic Retinopathy Study Research Group.
    Ophthalmology; 1991 May; 98(5 Suppl):823-33. PubMed ID: 2062515
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Computer-assisted microaneurysm turnover in the early stages of diabetic retinopathy.
    Bernardes R; Nunes S; Pereira I; Torrent T; Rosa A; Coelho D; Cunha-Vaz J
    Ophthalmologica; 2009; 223(5):284-91. PubMed ID: 19372722
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Growth hormone response to thyrotropin-releasing hormone in insulin-dependent diabetics with or without severe microvascular lesions.
    Blickle JF; Schlienger JL; de Laharpe F; Stephan F
    Diabete Metab; 1982 Sep; 8(3):197-201. PubMed ID: 6814964
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HYPOPHYSECTOMY FOR THE TREATMENT OF DIABETIC RETINOPATHY.
    PEARSON OH; RAY BS; MCLEAN JM; PERETZ WL; GREENBERG E; PAZIANOS A
    JAMA; 1964 Apr; 188():116-22. PubMed ID: 14107233
    [No Abstract]   [Full Text] [Related]  

  • 34. [Grading of diabetic retinopathy from non-stereoscopic color fundus photographs--relationship to fluorescein angiography findings and three-year prognosis].
    Kitano S
    Nippon Ganka Gakkai Zasshi; 2005 Sep; 109(9):563-72. PubMed ID: 16218434
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stabilization of severe proliferative diabetic retinopathy by long-term treatment with SMS 201-995.
    Mallet B; Vialettes B; Haroche S; Escoffier P; Gastaut P; Taubert JP; Vague P
    Diabete Metab; 1992; 18(6):438-44. PubMed ID: 1297600
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association between fluorescein leakage and optical coherence tomographic characteristics of microaneurysms in diabetic retinopathy.
    Ito H; Horii T; Nishijima K; Sakamoto A; Ota M; Murakami T; Yoshimura N
    Retina; 2013 Apr; 33(4):732-9. PubMed ID: 23190917
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Entoptic evaluation of diabetic retinopathy.
    Applegate RA; Bradley A; van Heuven WA; Lee BL; Garcia CA
    Invest Ophthalmol Vis Sci; 1997 Apr; 38(5):783-91. PubMed ID: 9112972
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effects of diethylstilbestrol and medroxyprogesterone acetate on kinetics and production of testosterone and dihydrotestosterone in patients with prostatic carcinoma.
    Nolten WE; Sholiton LJ; Srivastava LS; Knowles HC; Werk EE
    J Clin Endocrinol Metab; 1976 Dec; 43(6):1226-33. PubMed ID: 1002814
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Capillary microaneurysms and shunt vessels in diabetic retinopathy. Hypothesis on pathogenesis and prevention.
    Kornzweig AL
    Ann Ophthalmol; 1972 Jul; 4(7):589-94 passim. PubMed ID: 5046463
    [No Abstract]   [Full Text] [Related]  

  • 40. Pattern electroretinograms become abnormal when background diabetic retinopathy deteriorates to a preproliferative stage: possible use as a screening test.
    Arden GB; Hamilton AM; Wilson-Holt J; Ryan S; Yudkin JS; Kurtz A
    Br J Ophthalmol; 1986 May; 70(5):330-5. PubMed ID: 3964635
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.